We are live on ! Find out more
SRPT icon

Sarepta Therapeutics
SRPT

177 hedge funds and large institutions have $1.08B invested in Sarepta Therapeutics in 2016 Q4 according to their latest regulatory filings, with 43 funds opening new positions, 63 increasing their positions, 54 reducing their positions, and 50 closing their positions.

New
Increased
Maintained
Reduced
Closed

72.29% more ownership

Funds ownership: 0% → 72.29% (+72%)

17% more repeat investments, than reductions

Existing positions increased: 63 | Existing positions reduced: 54

9% more call options, than puts

Call options by funds: $212M | Put options by funds: $195M

5% less funds holding

Funds holding: 186 → 177 (-9)

14% less first-time investments, than exits

New positions opened: 43 | Existing positions closed: 50

58% less capital invested

Capital invested by funds: $2.59B → $1.08B (-$1.51B)

64% less funds holding in top 10

Funds holding in top 10: 11 → 4 (-7)

Holders
177
Holders Change
-9
Holders Change %
-4.84%
% of All Funds
4.42%
Holding in Top 10
4
Holding in Top 10 Change
-7
Holding in Top 10 Change %
-63.64%
% of All Funds
0.1%
New
43
Increased
63
Reduced
54
Closed
50
Calls
$212M
Puts
$195M
Net Calls
+$17.1M
Net Calls Change
+$274M

Top Buyers

1
CC
Carlson Capital
Texas
+$88.5M
2
SM
Sabby Management
Florida
+$59.4M
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$27.9M
4
BFA
BlackRock Fund Advisors
California
+$21.6M
5
CCM
Cadian Capital Management
New York
+$14M

Top Sellers

1
Point72 Asset Management
Point72 Asset Management
Connecticut
-$77M
2
Millennium Management
Millennium Management
New York
-$64.8M
3
JG
Jefferies Group
New York
-$59.3M
4
RG
Redmile Group
California
-$39.3M
5
Jennison Associates
Jennison Associates
New York
-$33.4M
Name Holding Trade Value Shares
Change 		Change in
Stake
BlackRock
51
BlackRock
New York
$3.22M +$332K +8,256 +8%
CG
52
Cutler Group
California
$3.12M +$2M +49,885 +78%
O
53
OppenheimerFunds
New York
$2.86M +$12.5K +310 +0.3%
PPA
54
Parametric Portfolio Associates
Washington
$2.86M -$1.76M -43,908 -30%
California State Teachers Retirement System (CalSTRS)
55
California State Teachers Retirement System (CalSTRS)
California
$2.84M +$518K +12,900 +14%
JGC
56
J. Goldman & Co
New York
$2.74M +$3.84M +95,525 +2,183%
Creative Planning
57
Creative Planning
Kansas
$2.72M +$2.15M +53,625 +117%
UBS Group
58
UBS Group
Switzerland
$2.55M -$850K -21,167 -19%
GC
59
Guggenheim Capital
Illinois
$2.35M -$307K -7,641 -8%
HCMT
60
Highland Capital Management (Texas)
Texas
$2.35M +$3.44M +85,600 New
Swiss National Bank
61
Swiss National Bank
Switzerland
$2.25M – – –
Barclays
62
Barclays
United Kingdom
$2.19M +$2.58M +64,192 +414%
CS
63
Credit Suisse
Switzerland
$2.01M -$165K -4,116 -5%
AllianceBernstein
64
AllianceBernstein
Tennessee
$1.99M +$390K +9,700 +15%
Wells Fargo
65
Wells Fargo
California
$1.87M +$1.21M +30,093 +79%
JP Morgan Chase
66
JP Morgan Chase
New York
$1.74M -$201K -5,000 -7%
Bank of America
67
Bank of America
North Carolina
$1.74M +$396K +9,868 +18%
Allianz Asset Management
68
Allianz Asset Management
Germany
$1.68M +$2.45M +61,093 New
GPCM
69
Granite Point Capital Management
Massachusetts
$1.65M -$4.02M -100,000 -63%
RhumbLine Advisers
70
RhumbLine Advisers
Massachusetts
$1.59M +$415K +10,323 +22%
PAMU
71
Pictet Asset Management (UK)
United Kingdom
$1.49M +$2.18M +54,200 New
New York State Common Retirement Fund
72
New York State Common Retirement Fund
New York
$1.45M +$235K +5,841 +12%
Renaissance Technologies
73
Renaissance Technologies
New York
$1.35M +$1.97M +49,078 New
Squarepoint
74
Squarepoint
New York
$1.28M +$1.88M +46,738 New
Nomura Holdings
75
Nomura Holdings
Japan
$1.24M +$1.8M +44,720 New
1 2
3
4 5

SRPT Hedge Fund Activity: Q4 2016 in Review

177 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Sarepta Therapeutics (SRPT) for Q4 2016, worth a combined $1.08B — down 58% from $2.59B a quarter earlier.

Sellers outnumbered buyers: 50 funds closed out of SRPT and 43 opened new positions — a net loss of 7 holders — while 54 trimmed existing stakes and 63 added.

The largest buyer was Carlson Capital, opening a new position worth an estimated $88.5M. The largest seller was Point72 Asset Management, cutting an estimated $77M.

  • 177 institutional investors held Sarepta Therapeutics (SRPT) as of Q4 2016, down from 186 in Q3 2016.
  • Funds reported $1.08B of Sarepta Therapeutics stock for Q4 2016, down 58% quarter-over-quarter.
  • 43 funds opened new Sarepta Therapeutics positions in Q4 2016 and 50 closed out, a net change of -7 holders.
  • The largest Sarepta Therapeutics buyer in Q4 2016 was Carlson Capital, an estimated $88.5M added.
  • The largest Sarepta Therapeutics seller in Q4 2016 was Point72 Asset Management, an estimated $77M sold.

Based on aggregated 13F filings for Q4 2016.